Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is uncle...
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Galenos Publishing House
2022-06-01
|
| Saila: | The Journal of Pediatric Academy |
| Gaiak: | |
| Sarrera elektronikoa: | https://jpediatricacademy.com/index.php/jpa/article/view/182 |
| Gaia: | Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to guide the evaluation of patients and management of those diagnosed with MIS-C. |
|---|---|
| ISSN: | 2718-0875 |